HEY IS THIS THREAD IN NEED OF CPR????
Please excuse typos:
The pipeline is still full and good news keeps coming. My May issue from Standard and Poor's writes" (MDT) should resume high double-digit earnings growth in the years ahead, as promising new products enable it to achieve gereater penetration of fast growing medical device markets. We expect profits in fiscal 1999 to reach $1.50 a share, up from an estimated .99 in fiscal 1998. Bolstered by its new Kappa series pacemakers, MDT should be ablt to increase by a few percentage points ins current 50% share of thre worldwide pacing market."
Article goes on about Gem DR rate-responsive, dual chamber implantable defibrillator, SynchroMed drug infusion system, Activa device for Parkinson's disease, Intrathecal device for cerebral and spinal spasticity. Working on devices to treat atrial fibrillation, most common heart rhythm disorder. Dividend is .22 per share, has risen 214% over last 5 years. Trades at about 35 times 1999 earnings.
"We expect these stocks to provide appreciation and divident growth that will beat the market in the months ahead" . (General comment about 4 stocks they reviewed).
Good luck to all, I plan on adding AFTER the next BIG dip and holding long term, FWIW.
They (MDT) have invested heavily in RBOT and LIFC which I follow and own. (I mean I own some stock NOT the company). ggg :o) |
